{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T08:54:59Z","timestamp":1791104099004,"version":"4.1.0"},"reference-count":49,"publisher":"MathDoc\/Centre Mersenne","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>Les syndromes lipodystrophiques forment un groupe h\u00e9t\u00e9rog\u00e8ne de pathologies cong\u00e9nitales ou acquises. La lipodystrophie, alt\u00e9ration de la quantit\u00e9 et\/ou de la r\u00e9partition de tissu adipeux, va entra\u00eener des anomalies glucido-lipidiques centr\u00e9es sur une r\u00e9sistance \u00e0 l'insuline. Les formes g\u00e9n\u00e9tiques, rares, sont g\u00e9n\u00e9ralis\u00e9es et r\u00e9cessives dans le cadre des mutations de la seipine ou d'AGPAT2. Des formes partielles dominantes sont observ\u00e9es chez des patients porteurs de mutations sur les g\u00e8nes codant PPAR-\u03b3 ou la lamine A\/C, les mutations lamine pouvant donner \u00e9galement des syndromes prog\u00e9ro\u00efdes. Les formes acquises, tr\u00e8s fr\u00e9quentes, concernent le syndrome m\u00e9tabolique, les hypercorticismes, ainsi que les complications lipodystrophiques des traitements anti-r\u00e9troviraux de l'infection VIH.<\/jats:p>","DOI":"10.1016\/j.crvi.2005.11.008","type":"journal-article","created":{"date-parts":[[2006,5,3]],"date-time":"2006-05-03T09:21:51Z","timestamp":1146648111000},"page":"639-652","source":"Crossref","is-referenced-by-count":12,"title":["Les syndromes lipodystrophiques : des adipopathies cong\u00e9nitales ou acquises"],"prefix":"10.5802","volume":"329","author":[{"given":"Jacqueline","family":"Capeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Vigouroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyne","family":"Magr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lascols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Philippe","family":"Bastard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3842","published-online":{"date-parts":[[2006,4,27]]},"reference":[{"key":"key2025102316282365446_1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"18","author":"Garg, A.","year":"2004","unstructured":"[1] Garg, A. Acquired and inherited lipodystrophies, N. Engl. J. Med., Volume 18 (2004), pp. 1220-1234","journal-title":"N. Engl. J. Med."},{"key":"key2025102316282365446_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.biochi.2004.11.007","article-title":"The human adipose tissue is a source of multipotent stem cells","volume":"87","author":"Rodriguez, A.M.","year":"2005","unstructured":"[2] Rodriguez, A.M.; Elabd, C.; Amri, E.Z.; Ailhaud, G.; Dani, C. The human adipose tissue is a source of multipotent stem cells, Biochimie, Volume 87 (2005), pp. 125-128","journal-title":"Biochimie"},{"key":"key2025102316282365446_3","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1101\/gad.12.20.3182","article-title":"Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy","volume":"15","author":"Shimomura, I.","year":"1998","unstructured":"[3] Shimomura, I.; Hammer, R.E.; Richardson, J.A.; Ikemoto, S.; Bashmakov, Y.; Goldstein, J.L.; Brown, M.S. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy, Genes Dev., Volume 15 (1998), pp. 3182-3194","journal-title":"Genes Dev."},{"key":"key2025102316282365446_4","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","article-title":"Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice","volume":"275","author":"Kim, J.K.","year":"2000","unstructured":"[4] Kim, J.K.; Gavrilova, O.; Chen, Y.; Reitman, M.L.; Shulman, G.I. Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice, J. Biol. Chem., Volume 275 (2000), pp. 8456-8460","journal-title":"J. Biol. Chem."},{"key":"key2025102316282365446_5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","article-title":"Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice","volume":"105","author":"Gavrilova, O.","year":"2000","unstructured":"[5] Gavrilova, O.; Marcus-Samuels, B.; Graham, D.; Kim, J.K.; Shulman, G.I.; Castle, A.L.; Vinson, C.; Eckhaus, M.; Reitman, M.L. Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice, J. Clin. Invest., Volume 105 (2000), pp. 271-278","journal-title":"J. Clin. Invest."},{"key":"key2025102316282365446_6","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm788","article-title":"Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase","volume":"8","author":"Yamauchi, T.","year":"2002","unstructured":"[6] Yamauchi, T.; Kamon, J.; Minokoshi, Y.; Ito, Y.; Waki, H.; Uchida, S.; Yamashita, S.; Noda, M.; Kita, S.; Ueki, K.; Eto, K.; Akanuma, Y.; Froguel, P.; Foufelle, F.; Ferre, P.; Carling, D.; Kimura, S.; Nagai, R.; Kahn, B.B.; Kadowaki, T. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase, Nat. Med., Volume 8 (2002), pp. 1288-1295","journal-title":"Nat. Med."},{"key":"key2025102316282365446_7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/ng585","article-title":"Identification of the gene altered in Berardinelli\u2013Seip congenital lipodystrophy on chromosome 11q13","volume":"28","author":"Magre, J.","year":"2001","unstructured":"[7] Magre, J.; Delepine, M.; Khallouf, E.; Gedde-Dahl, T. Jr.; Van Maldergem, L.; Sobel, E.; Papp, J.; Meier, M.; Megarbane, A.; Bachy, A.; Verloes, A.; d'Abronzo, F.H.; Seemanova, E.; Assan, R.; Baudic, N.; Bourut, C.; Czernichow, P.; Huet, F.; Grigorescu, F.; de Kerdanet, M.; Lacombe, D.; Labrune, P.; Lanza, M.; Loret, H.; Matsuda, F.; Navarro, J.; Nivelon-Chevalier, A.; Polak, M.; Robert, J.-J.; Tric, P.; Tubiana-Rufi, N.; Vigouroux, C.; Weissenbach, J.; Savasta, S.; Maassen, J.A.; Trygstad, O.; Bogalho, P.; Freitas, P.; Medina, J.L.; Bonnicci, F.; Joffe, B.I.; Loyson, G.; Panz, V.R.; Raal, F.J.; O'Rahilly, S.; Stephenson, T.; Kahn, C.R.; Lathrop, M.; Capeau, J.; BSCL Working Group Identification of the gene altered in Berardinelli\u2013Seip congenital lipodystrophy on chromosome 11q13, Nat. Genet., Volume 28 (2001), pp. 365-370","journal-title":"Nat. Genet."},{"key":"key2025102316282365446_8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ng1313","article-title":"Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome","volume":"36","author":"Windpassinger, C.","year":"2004","unstructured":"[8] Windpassinger, C.; Auer-Grumbach, M.; Irobi, J.; Patel, H.; Petek, E.; Horl, G.; Malli, R.; Reed, J.A.; Dierick, I.; Verpoorten, N.; Warner, T.T.; Proukakis, C.; Van den Bergh, P.; Verellen, C.; Van Maldergem, L.; Merlini, L.; De Jonghe, P.; Timmerman, V.; Crosby, A.H.; Wagner, K. Heterozygous missense mutations in BSCL2 are associated with distal hereditary motor neuropathy and Silver syndrome, Nat. Genet., Volume 36 (2004), pp. 271-276","journal-title":"Nat. Genet."},{"key":"key2025102316282365446_9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng880","article-title":"AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34","volume":"31","author":"Agarwal, A.K.","year":"2002","unstructured":"[9] Agarwal, A.K.; Arioglu, E.; De Almeida, S.; Akkoc, N.; Taylor, S.I.; Bowcock, A.M.; Barnes, R.I.; Garg, A. AGPAT2 is mutated in congenital generalized lipodystrophy linked to chromosome 9q34, Nat. Genet., Volume 31 (2002), pp. 21-23","journal-title":"Nat. Genet."},{"key":"key2025102316282365446_10","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/diabetes.52.6.1573","article-title":"Prevalence of mutations in AGPAT2 among human lipodystrophies","volume":"52","author":"Magre, J.","year":"2003","unstructured":"[10] Magre, J.; Delepine, M.; Van Maldergem, L.; Robert, J.-J.; Maassen, J.A.; Meier, M.; Panz, V.R.; Kim, C.A.; Tubiana-Rufi, N.; Czernichow, P.; Seemanova, E.; Buchanan, C.R.; Lacombe, D.; Vigouroux, C.; Lascols, O.; Kahn, C.R.; Capeau, J.; Lathrop, M. Prevalence of mutations in AGPAT2 among human lipodystrophies, Diabetes, Volume 52 (2003), pp. 1573-1578","journal-title":"Diabetes"},{"key":"key2025102316282365446_11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/jcem.85.2.6392","article-title":"Normal reproductive function in leptin-deficient patients with lipoatropic diabetes","volume":"85","author":"Andreelli, F.","year":"2000","unstructured":"[11] Andreelli, F.; Hanaire-Broutin, H.; Laville, M.; Tauber, J.-P.; Riou, J.-P.; Thivolet, C. Normal reproductive function in leptin-deficient patients with lipoatropic diabetes, J. Clin. Endocrinol. Metab., Volume 85 (2000), pp. 715-719","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key2025102316282365446_12","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1056\/NEJMoa012437","article-title":"Leptin-replacement therapy for lipodystrophy","volume":"346","author":"Oral, E.A.","year":"2002","unstructured":"[12] Oral, E.A.; Simha, V.; Ruiz, E.; Andewelt, A.; Premkumar, A.; Snell, P.; Wagner, A.J.; DePaoli, A.M.; Reitman, M.L.; Taylor, S.I.; Gorden, P.; Garg, A. Leptin-replacement therapy for lipodystrophy, N. Engl. J. Med., Volume 346 (2002), pp. 570-578","journal-title":"N. Engl. J. Med."},{"key":"key2025102316282365446_13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"A family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"28","author":"George, S.","year":"2004","unstructured":"[13] George, S.; Rochford, J.J.; Wolfrum, C.; Gray, S.L.; Schinner, S.; Wilson, J.C.; Soos, M.A.; Murgatroyd, P.R.; Williams, R.M.; Acerini, C.L.; Dunger, D.B.; Barford, D.; Umpleby, A.M.; Wareham, N.J.; Davies, H.A.; Schafer, A.J.; Stoffel, M.; O'Rahilly, S.; Barroso, I. A family with severe insulin resistance and diabetes due to a mutation in AKT2, Science, Volume 28 (2004), pp. 1325-1328","journal-title":"Science"},{"key":"key2025102316282365446_14","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.2337\/diabetes.49.11.1958","article-title":"Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy","volume":"49","author":"Vigouroux, C.","year":"2000","unstructured":"[14] Vigouroux, C.; Magre, J.; Vantyghem, M.C.; Bourut, C.; Lascols, O.; Shackleton, S.; Lloyd, D.J.; Guerci, B.; Padova, G.; Valensi, P.; Grimaldi, A.; Piquemal, R.; Touraine, P.; Trembath, R.C.; Capeau, J. Lamin A\/C gene: sex-determined expression of mutations in Dunnigan-type familial partial lipodystrophy and absence of coding mutations in congenital and acquired generalized lipoatrophy, Diabetes, Volume 49 (2000), pp. 1958-1962","journal-title":"Diabetes"},{"key":"key2025102316282365446_15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/nm0705-718","article-title":"Genome instability in progeria: when repair gets old","volume":"11","author":"Misteli, T.","year":"2005","unstructured":"[15] Misteli, T.; Scaffidi, P. Genome instability in progeria: when repair gets old, Nat. Med., Volume 11 (2005), pp. 718-719","journal-title":"Nat. Med."},{"key":"key2025102316282365446_16","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/6799","article-title":"Mutations in the gene encoding lamin A\/C cause autosomal dominant \u00c9mery\u2013Dreyfuss muscular dystrophy","volume":"21","author":"Bonne, G.","year":"1999","unstructured":"[16] Bonne, G.; Di Barletta, M.R.; Varnous, S.; Becane, H.M.; Hammouda, E.H.; Merlini, L.; Muntoni, F.; Greenberg, C.R.; Gary, F.; Urtizberea, J.A.; Duboc, D.; Fardeau, M.; Toniolo, D.; Schwartz, K. Mutations in the gene encoding lamin A\/C cause autosomal dominant \u00c9mery\u2013Dreyfuss muscular dystrophy, Nat. Genet., Volume 21 (1999), pp. 285-288","journal-title":"Nat. Genet."},{"key":"key2025102316282365446_17","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/hmg\/9.1.109","article-title":"Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy","volume":"9","author":"Cao, H.","year":"2000","unstructured":"[17] Cao, H.; Hegele, R.A. Nuclear lamin A\/C R482Q mutation in Canadian kindreds with Dunnigan-type familial partial lipodystrophy, Hum. Mol. Genet., Volume 9 (2000), pp. 109-112","journal-title":"Hum. Mol. Genet."},{"key":"key2025102316282365446_18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton, S.","year":"2000","unstructured":"[18] Shackleton, S.; Lloyd, D.J.; Jackson, S.N.; Evans, R.; Niermeijer, M.F.; Singh, B.M.; Schmidt, H.; Brabant, G.; Kumar, S.; Durrington, P.N.; Gregory, S.; O'Rahilly, S.; Trembath, R.C. LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy, Nat. Genet., Volume 24 (2000), pp. 153-156","journal-title":"Nat. Genet."},{"key":"key2025102316282365446_19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S0003-4266(05)81761-5","article-title":"Laminopathies: lipodystrophies, insulin resistance, syndromes of accelerated ageing... and others","volume":"66","author":"Vigouroux, C.","year":"2005","unstructured":"[19] Vigouroux, C. Laminopathies: lipodystrophies, insulin resistance, syndromes of accelerated ageing... and others, Ann. Endocrinol., Volume 66 (2005), pp. 270-278","journal-title":"Ann. Endocrinol."},{"key":"key2025102316282365446_20","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/jc.2002-021506","article-title":"A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy","volume":"88","author":"Caux, F.","year":"2003","unstructured":"[20] Caux, F.; Dubosclard, E.; Lascols, O.; Buendia, B.; Chazouilleres, O.; Cohen, A.; Courvalin, J.-C.; Laroche, L.; Capeau, J.; Vigouroux, C.; Christin-Ma\u00eetre, S. A new clinical condition linked to a novel mutation in lamins A and C with generalized lipoatrophy, insulin-resistant diabetes, disseminated leukomelanodermic papules, liver steatosis, and cardiomyopathy, J. Clin. Endocrinol. Metab., Volume 88 (2003), pp. 1006-1013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"key2025102316282365446_21","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/diabetes.54.6.1873","article-title":"Type-A insulin resistance syndrome revealing a novel lamin A mutation","volume":"54","author":"Young, J.","year":"2005","unstructured":"[21] Young, J.; Morbois-Trabut, L.; Couzinet, B.; Lascols, O.; Dion, E.; Bereziat, V.; Feve, B.; Richard, I.; Capeau, J.; Chanson, P.; Vigouroux, C. Type-A insulin resistance syndrome revealing a novel lamin A mutation, Diabetes, Volume 54 (2005), pp. 1873-1878","journal-title":"Diabetes"},{"key":"key2025102316282365446_22","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1242\/jcs.114.24.4459","article-title":"Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q\/W mutations in the lamin A\/C gene","volume":"114","author":"Vigouroux, C.","year":"2001","unstructured":"[22] Vigouroux, C.; Auclair, M.; Dubosclard, E.; Pouchelet, M.; Capeau, J.; Courvalin, J.C.; Buendia, B. Nuclear envelope disorganization in fibroblasts from lipodystrophic patients with heterozygous R482Q\/W mutations in the lamin A\/C gene, J. Cell Sci., Volume 114 (2001), pp. 4459-4468","journal-title":"J. Cell Sci."},{"issue":"3","key":"key2025102316282365446_23","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200419670","article-title":"Lamin A\/C deficiency causes defective nuclear mechanics and mechanotransduction","volume":"113","author":"Lammerding, J.","year":"2004","unstructured":"[23] Lammerding, J.; Schulze, P.C.; Takahashi, T.; Kozlov, S.; Sullivan, T.; Kamm, R.D.; Stewart, C.L.; Lee, R.T. Lamin A\/C deficiency causes defective nuclear mechanics and mechanotransduction, J. Clin. Invest., Volume 113 (2004) no. 3, pp. 370-378","journal-title":"J. Clin. Invest."},{"key":"key2025102316282365446_24","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/hmg\/11.7.769","article-title":"A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies","volume":"11","author":"Lloyd, D.J.","year":"2002","unstructured":"[24] Lloyd, D.J.; Trembath, R.C.; Shackleton, S. A novel interaction between lamin A and SREBP1: implications for partial lipodystrophy and other laminopathies, Hum. Mol. Genet., Volume 11 (2002), pp. 769-777","journal-title":"Hum. Mol. Genet."},{"key":"key2025102316282365446_25","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1126\/science.1084125","article-title":"Lamin-A truncation in Hutchinson\u2013Gilford progeria","volume":"300","author":"De Sandre-Giovannoli, A.","year":"2003","unstructured":"[25] De Sandre-Giovannoli, A.; Bernard, R.; Cau, P.; Navarro, C.; Amiel, J.; Boccaccio, I.; Lyonnet, S.; Stewart, C.L.; Munnich, A.; Le Merrer, M.; Levy, N. Lamin-A truncation in Hutchinson\u2013Gilford progeria, Science, Volume 300 (2003), p. 2055","journal-title":"Science"},{"key":"key2025102316282365446_26","doi-asserted-by":"crossref","first-page":"18111","DOI":"10.1073\/pnas.0408558102","article-title":"Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice","volume":"101","author":"Fong, L.G.","year":"2004","unstructured":"[26] Fong, L.G.; Ng, J.K.; Meta, M.; Cote, N.; Yang, S.H.; Stewart, C.L.; Sullivan, T.; Burghardt, A.; Majumdar, S.; Reue, K.; Bergo, M.O.; Young, S.G. Heterozygosity for Lmna deficiency eliminates the progeria-like phenotypes in Zmpste24-deficient mice, Proc. Natl Acad. Sci. USA, Volume 101 (2004), pp. 18111-18116","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key2025102316282365446_27","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nm1266","article-title":"Genomic instability in laminopathy-based premature aging","volume":"11","author":"Liu, B.","year":"2005","unstructured":"[27] Liu, B.; Wang, J.; Chan, K.M.; Tjia, W.M.; Deng, W.; Guan, X.; Huang, J.D.; Li, K.M.; Chau, P.Y.; Chen, D.J.; Pei, D.; Pendas, A.M.; Cadinanos, J.; Lopez-Otin, C.; Tse, H.F.; Hutchison, C.; Chen, J.; Cao, Y.; Cheah, K.S.; Tryggvason, K.; Zhou, Z. Genomic instability in laminopathy-based premature aging, Nat. Med., Volume 11 (2005), pp. 780-785","journal-title":"Nat. Med."},{"key":"key2025102316282365446_28","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/nature04019","article-title":"Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation","volume":"437","author":"Varela, I.","year":"2005","unstructured":"[28] Varela, I.; Cadinanos, J.; Pendas, A.M.; Gutierrez-Fernandez, A.; Folgueras, A.R.; Sanchez, L.M.; Zhou, Z.; Rodriguez, F.J.; Stewart, C.L.; Vega, J.A.; Tryggvason, K.; Freije, J.M.; Lopez-Otin, C. Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation, Nature, Volume 437 (2005), pp. 564-568","journal-title":"Nature"},{"key":"key2025102316282365446_29","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso, I.","year":"1999","unstructured":"[29] Barroso, I.; Gurnell, M.; Crowley, V.E.; Agostini, M.; Schwabe, J.W.; Soos, M.A.; Maslen, G.L.; Williams, T.D.; Lewis, H.; Schafer, A.J.; Chatterjee, V.K.; O'Rahilly, S. Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension, Nature, Volume 402 (1999), pp. 880-883","journal-title":"Nature"},{"key":"key2025102316282365446_30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome \u2013 A new worldwide definition","volume":"366","author":"Alberti, K.G.","year":"2005","unstructured":"[30] Alberti, K.G.; Zimmet, P.; Shaw, J.; IDF Epidemiology Task Force Consensus Group The metabolic syndrome \u2013 A new worldwide definition, Lancet, Volume 366 (2005), pp. 1059-1062","journal-title":"Lancet"},{"key":"key2025102316282365446_31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(05)66374-X","article-title":"Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study","volume":"365","author":"Van Gaal, L.F.","year":"2005","unstructured":"[31] Van Gaal, L.F.; Rissanen, A.M.; Scheen, A.J.; Ziegler, O.; Rossner, S.; RIO-Europe Study Group Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, Lancet, Volume 365 (2005), pp. 1389-1397","journal-title":"Lancet"},{"key":"key2025102316282365446_32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and body-fat abnormalities in HIV-infected adults","volume":"352","author":"Grinspoon, S.","year":"2005","unstructured":"[32] Grinspoon, S.; Carr, A. Cardiovascular risk and body-fat abnormalities in HIV-infected adults, N. Engl. J. Med., Volume 352 (2005), pp. 48-62","journal-title":"N. Engl. J. Med."},{"key":"key2025102316282365446_33","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0166-3542(01)00148-6","article-title":"Metabolic complications associated with antiretroviral therapy","volume":"51","author":"Jain, R.G.","year":"2001","unstructured":"[33] Jain, R.G.; Furfine, E.S.; Pedneault, L.; White, A.J.; Lenhard, J.M. Metabolic complications associated with antiretroviral therapy, Antiviral Res., Volume 51 (2001), pp. 151-177","journal-title":"Antiviral Res."},{"key":"key2025102316282365446_34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/135965350400900206","article-title":"Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations","volume":"9","author":"Gougeon, M.L.","year":"2004","unstructured":"[34] Gougeon, M.L.; Penicaud, L.; Fromenty, B.; Leclercq, P.; Viard, J.-P.; Capeau, J. Adipocytes targets and actors in the pathogenesis of HIV-associated lipodystrophy and metabolic alterations, Antivir. Ther., Volume 9 (2004), pp. 161-177","journal-title":"Antivir. Ther."},{"key":"key2025102316282365446_35","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1177\/135965350400900609","article-title":"Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms","volume":"9","author":"Nolan, D.","year":"2004","unstructured":"[35] Nolan, D.; Mallal, S. Complications associated with NRTI therapy: update on clinical features and possible pathogenic mechanisms, Antivir. Ther., Volume 9 (2004), pp. 849-863","journal-title":"Antivir. Ther."},{"key":"key2025102316282365446_36","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1097\/00002030-200411050-00004","article-title":"HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro","volume":"18","author":"Caron, M.","year":"2004","unstructured":"[36] Caron, M.; Auclair, M.; Lagathu, C.; Lombes, A.; Walker, U.A.; Kornprobst, M.; Capeau, J. HIV-1 nucleoside reverse transcriptase inhibitors stavudine and zidovudine alter adipocyte functions in vitro, AIDS, Volume 18 (2004), pp. 2127-2136","journal-title":"AIDS"},{"key":"key2025102316282365446_37","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1177\/135965350400900607","article-title":"Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro","volume":"9","author":"Lagathu, C.","year":"2004","unstructured":"[37] Lagathu, C.; Bastard, J.-P.; Auclair, M.; Maachi, M.; Kornprobst, M.; Capeau, J.; Caron, M. Antiretroviral drugs with adverse effects on adipocyte lipid metabolism and survival alter the expression and secretion of proinflammatory cytokines and adiponectin in vitro, Antivir. Ther., Volume 9 (2004), pp. 911-920","journal-title":"Antivir. Ther."},{"key":"key2025102316282365446_38","doi-asserted-by":"crossref","first-page":"41325","DOI":"10.1074\/jbc.M006474200","article-title":"Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors","volume":"275","author":"Dowell, P.","year":"2000","unstructured":"[38] Dowell, P.; Flexner, C.; Kwiterovich, P.O.; Lane, M.D. Suppression of preadipocyte differentiation and promotion of adipocyte death by HIV protease inhibitors, J. Biol. Chem., Volume 275 (2000), pp. 41325-41332","journal-title":"J. Biol. Chem."},{"key":"key2025102316282365446_39","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.2337\/diabetes.50.6.1378","article-title":"The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance","volume":"50","author":"Caron, M.","year":"2001","unstructured":"[39] Caron, M.; Auclair, M.; Vigouroux, C.; Glorian, M.; Forest, C.; Capeau, J. The HIV protease inhibitor indinavir impairs sterol regulatory element-binding protein-1 intranuclear localization, inhibits preadipocyte differentiation, and induces insulin resistance, Diabetes, Volume 50 (2001), pp. 1378-1388","journal-title":"Diabetes"},{"key":"key2025102316282365446_40","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1097\/00002030-200311210-00005","article-title":"Some HIV protease inhibitors alter lamin A\/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation","volume":"17","author":"Caron, M.","year":"2003","unstructured":"[40] Caron, M.; Auclair, M.; Sterlingot, H.; Kornprobst, M.; Capeau, J. Some HIV protease inhibitors alter lamin A\/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation, AIDS, Volume 17 (2003), pp. 2437-2444","journal-title":"AIDS"},{"key":"key2025102316282365446_41","doi-asserted-by":"crossref","first-page":"15130","DOI":"10.1074\/jbc.M312875200","article-title":"In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes","volume":"279","author":"Hadri, K.E.","year":"2004","unstructured":"[41] Hadri, K.E.; Glorian, M.; Monsempes, C.; Dieudonne, M.N.; Pecquery, R.; Giudicelli, Y.; Andreani, M.; Dugail, I.; Feve, B. In vitro suppression of the lipogenic pathway by the nonnucleoside reverse transcriptase inhibitor efavirenz in 3T3 and human preadipocytes or adipocytes, J. Biol. Chem., Volume 279 (2004), pp. 15130-15141","journal-title":"J. Biol. Chem."},{"key":"key2025102316282365446_42","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin, A.","year":"2004","unstructured":"[42] Martin, A.; Smith, D.E.; Carr, A.; Ringland, C.; Amin, J.; \u00c9mery, S.; Hoy, J.; Workman, C.; Doong, N.; Freund, J.; Cooper, D.A.; Mitochondrial Toxicity Study Group Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study, AIDS, Volume 18 (2004), pp. 1029-1036","journal-title":"AIDS"},{"key":"key2025102316282365446_43","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1097\/00002030-199911120-00008","article-title":"Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy","volume":"13","author":"Domingo, P.","year":"1999","unstructured":"[43] Domingo, P.; Matias-Guiu, X.; Pujol, R.M.; Francia, E.; Lagarda, E.; Sambeat, M.A.; Vazquez, G. Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy, AIDS, Volume 13 (1999), pp. 2261-2267","journal-title":"AIDS"},{"key":"key2025102316282365446_44","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/00002030-200306130-00007","article-title":"Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy","volume":"17","author":"Nolan, D.","year":"2003","unstructured":"[44] Nolan, D.; Hammond, E.; Martin, A.; Taylor, L.; Herrmann, S.; McKinnon, E.; Metcalf, C.; Latham, B.; Mallal, S. Mitochondrial DNA depletion and morphologic changes in adipocytes associated with nucleoside reverse transcriptase inhibitor therapy, AIDS, Volume 17 (2003), pp. 1329-1338","journal-title":"AIDS"},{"key":"key2025102316282365446_45","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1177\/135965350400900412","article-title":"Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients","volume":"9","author":"Jan, V.","year":"2004","unstructured":"[45] Jan, V.; Cervera, P.; Maachi, M.; Baudrimont, M.; Kim, M.; Vidal, H.; Girard, P.M.; Levan, P.; Rozenbaum, W.; Lombes, A.; Capeau, J.; Bastard, J.-P. Altered fat differentiation and adipocytokine expression are inter-related and linked to morphological changes and insulin resistance in HIV-1-infected lipodystrophic patients, Antivir. Ther., Volume 9 (2004), pp. 555-564","journal-title":"Antivir. Ther."},{"key":"key2025102316282365446_46","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/S0140-6736(02)08094-7","article-title":"Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance","volume":"359","author":"Bastard, J.-P.","year":"2002","unstructured":"[46] Bastard, J.-P.; Caron, M.; Vidal, H.; Jan, V.; Auclair, M.; Vigouroux, C.; Luboinski, J.; Laville, M.; Maachi, M.; Girard, P.M.; Rozenbaum, W.; Levan, P.; Capeau, J. Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance, Lancet, Volume 359 (2002), pp. 1026-1031","journal-title":"Lancet"},{"key":"key2025102316282365446_47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00125-003-1284-4","article-title":"11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes","volume":"47","author":"Stulnig, T.M.","year":"2004","unstructured":"[47] Stulnig, T.M.; Waldhausl, W. 11beta-Hydroxysteroid dehydrogenase Type 1 in obesity and Type 2 diabetes, Diabetologia, Volume 47 (2004), pp. 1-11","journal-title":"Diabetologia"},{"key":"key2025102316282365446_48","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/01.CIR.103.18.2225","article-title":"Premature atherosclerosis associated with monogenic insulin resistance","volume":"103","author":"Hegele, R.A.","year":"2001","unstructured":"[48] Hegele, R.A. Premature atherosclerosis associated with monogenic insulin resistance, Circulation, Volume 103 (2001), pp. 2225-2229","journal-title":"Circulation"},{"key":"key2025102316282365446_49","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1056\/NEJMoa031314","article-title":"Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes","volume":"350","author":"Petersen, K.F.","year":"2004","unstructured":"[49] Petersen, K.F.; Dufour, S.; Befroy, D.; Garcia, R.; Shulman, G.I. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes, N. Engl. J. Med., Volume 350 (2004), pp. 664-671","journal-title":"N. Engl. J. Med."}],"container-title":["Comptes Rendus. Biologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/comptes-rendus.academie-sciences.fr\/biologies\/item\/10.1016\/j.crvi.2005.11.008.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T14:33:24Z","timestamp":1761230004000},"score":1,"resource":{"primary":{"URL":"https:\/\/comptes-rendus.academie-sciences.fr\/biologies\/articles\/10.1016\/j.crvi.2005.11.008\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,27]]},"references-count":49,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2006]]}},"alternative-id":["10.1016\/j.crvi.2005.11.008"],"URL":"https:\/\/doi.org\/10.1016\/j.crvi.2005.11.008","relation":{},"ISSN":["1631-0691","1768-3238"],"issn-type":[{"value":"1631-0691","type":"print"},{"value":"1768-3238","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,27]]}}}